Study design
The study was a multicenter, randomised controlled trial with randomisation of individual patients into either of two arms: (1) CMAP plus E-TAU and (2) E-TAU alone. The trial is reported in accordance with the guidance of the Consolidated Standards of Reporting Trials (CONSORT).